Catalyst Wire Dossier Catalyst Wire Dossier

Nexavar (sorafenib)

sorafenib · Bayer
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for Nexavar (sorafenib), covering 2009-07-07 to 2019-02-15. Get the full timeline:

Most recent: Clinical Trial Update: Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma [NA]

See pricing